Leasinvest Real Estate NV: Publication of a transparency notification



A notification of 20 July 2021 issued by Ackermans & van Haaren NV shows that both a passive threshold overrun and an acquisition of voting securities took place, following the introduction of the double voting rights and a capital increase by contribution in kind from a/o Extensa Group, as approved at the extraordinary general meeting of Leasinvest Real Estate on 19 July 2021. The total number of voting rights of Ackermans & van Haaren NV in Leasinvest Real Estate has increased, so that Ackermans & van Haaren NV now holds 64.66% of the voting rights in Leasinvest Real Estate NV (hereinafter the "Company").

The notification comprises the following information:

REASON FOR THE NOTIFICATION: Acquisition or disposal of voting securities or voting rights - Passive threshold overrun

NOTIFICATION: by the parent company or controlling person.


Name and legal formAddress
Stichting Administratiekantoor "Het Torentje" Parklaan 34, 3018 BC Rotterdam, Nederland
Ackermans & van Haaren NV Begijnenvest 113, 2000 Antwerp
Leasinvest Services NV Schermersstraat 42, 2000 Antwerp



DENOMINATOR: 11,804,919


A) Voting rights Previous notification* After the transaction
# voting rights # voting rights % voting rights
Holders of voting rights Related to securities Unrelated to securities Related to securities Unrelated to securities
Stichting Administratiekantoor "Het Torentje" 0 0 0.00%
Ackermans & van Haaren NV 1 481 959 7 632 176 64.65%
Leasinvest Real Estate Management NV 6 0 0.00%
Leasinvest Services NV 204 408 0.00%
Sub-total 1 482 169 7 632 584 64.66%
TOTAL 7 632 584 64.66%

*based on a denominator of 4,938,870

B) Equivalent financial instruments After the transaction
Holders of equivalent financial instruments Type of financial instrument

Exercise period or date
# voting rights that can be acquired if the financial instrument is exercised % voting rights Settlement
0 0,00%

TOTAL (A & B) # voting rights % voting rights
7 632 58464.66%

Additional information

This notification concerns both a passive threshold overrun and an acquisition of voting securities, following the introduction of double voting rights and a capital increase by contribution in kind from a/o Extensa Group, as approved at the extraordinary general meeting of Leasinvest Real Estate on 19 July 2021.

Full chain of control of the companies via which the participation is effectively held

Chain of control of Leasinvest Services NV

  1. Leasinvest Services NV is directly controlled by Leasinvest Real Estate NV, a company under Belgian law.
  2. Leasinvest Real Estate NV is directly controlled by Ackermans & van Haaren NV, a company under Belgian law.

Chain of control of Ackermans & van Haaren NV

  1. Ackermans & van Haaren NV is directly controlled by Scaldis Invest NV, a company under Belgian law.
  2. Scaldis Invest NV is directly controlled by Belfimas NV, a company under Belgian law.
  3. Belfimas NV is directly controlled by Celfloor S.A., a company under Luxembourg law.
  4. Celfloor S.A. is directly controlled by Apodia International Holding B.V., a company under Dutch law.
  5. Apodia International Holding B.V. is directly controlled by Palamount S.A., a company under Luxembourg law.
  6. Palamount S.A. is directly controlled by “Het Torentje”, a ‘stichting administratiekantoo’r created under Dutch law.
  7. Stichting administratiekantoor “Het Torentje” is the ultimate controlling shareholder.

In accordance with Article 11 §1 of the Act of 2 May 2007, the stichting administratiekantoor “Het Torentje” acts in its own name and on behalf of the companies listed under (ii) to (vi).


The notice as well as the shareholder structure can be consulted on the Company's website

In accordance with Article 28 of the Articles of Association, the double voting rights - which were introduced on the basis of the decision of the Extraordinary General Meeting of the Company of 19 July 2021 - shall be granted to each fully paid-up share of the Company that has been continuously registered in the register of registered shares in the name of the same shareholder for a period of at least two years. The remaining shares entitle to one vote. The two-year period shall begin to run from the date of registration of the nominative shares in the share register.

Leasinvest Real Estate NV uses the LIFO method ("last in, first out") to calculate the period of two consecutive years. For the same registered shareholder, the shares it last acquired shall be the first shares to be deducted from its global holdings of the Company's nominative shares upon subsequent transfer or dematerialisation, unless the request for dematerialisation or transfer documentation expressly provides otherwise.

For more information, contact

Leasinvest Real Estate NV

Chief Executive Officer
T: +32 3 238 98 77

Leasinvest Real Estate NV is a mixed real estate investor and developer.

The total value of the investment portfolio is approximately EUR 1.4 billion, distributed among the Grand Duchy of Luxembourg (45%), Belgium (42%) and Austria (13%).

Leasinvest is one of the largest real estate investors in Luxembourg.

The total value of the development portfolio is approximately EUR 0.3 billion and is distributed among the Sites of Tour&Taxis and Cloche d'Or, on which mixed developments (residential and offices) are ongoing and on which new subprojects will be launched in the coming years.

The Company is listed on Euronext Brussels and has a market capitalisation of € 671 million (value 22 July 2021).


To view this piece of content from, please give your consent at the top of this page.
To view this piece of content from, please give your consent at the top of this page.

About GlobeNewswire

One Liberty Plaza - 165 Broadway
NY 10006 New York

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

Leading Edge Materials Announces Filing of Preliminary Economic Assessment Report for Woxna Graphite Anode Project26.7.2021 14:30:00 CEST | Press release

Vancouver, July 26, 2021 – Leading Edge Materials Corp. (“Leading Edge Materials” or the “Company”) (TSXV: LEM) (Nasdaq First North: LEMSE) (OTCQB: LEMIF) is pleased to announce that the technical report for its Woxna Graphite project (the “Project”) titled “NI 43-101 Technical Report – Woxna Graphite” with effective date June 9, 2021, has been filed under the Company’s profile on SEDAR today (the “Report” or “PEA”). The Report supports the disclosure in the Company’s news release dated June 9, 2021. All figures in the Report are US dollars unless otherwise specified. The news release on June 9, 2021, presented these highlights of the Report: Main PEA Highlights The PEA indicates the potential viability of a Swedish operation producing battery grade graphite anode material utilizing an existing graphite mine and concentrator with the addition of a value-add processing facility offsite;The proposed process route in the PEA uses a thermal purification process which, combined with access

Cavotec wins key motorised cable reel order for advanced container cranes in Japan26.7.2021 09:00:00 CEST | Press release

Cavotec has won a key order for its innovative motorised cable reel systems for integration onto advanced rail-mounted gantry cranes at the Port of Tokyo – a project that highlights Cavotec’s position as a trusted supplier of mission-critical systems at ports and terminals. “Given the complexity of these high-end cranes and their demanding operational environment, this is an excellent reference for us as we continue to grow in Japan and the wider region,” says Robin Shang, Cavotec Regional Sales Director Ports & Maritime. Cavotec will supply motorised cable reel systems for eight automated rail-mounted gantry (ARMG) cranes at the Wan Hai Tokyo Oi5 terminal, a major global container handling hub. The cable reels will ensure the cranes meet demanding performance requirements due to surging container volumes. Working closely with Chin Pan engineering group, Cavotec is scheduled to complete the delivery of the systems in early 2023. Previously, Chin Pan has fitted two ARMGs cranes successf

Scandinavian Tobacco Group A/S: Transactions in connection with share buy-back programme26.7.2021 08:44:35 CEST | Press release

Company Announcement No. 38/2021 Copenhagen, 26 July 2021 Transactions in connection with share buy-back programme On 10 March 2021, Scandinavian Tobacco Group A/S (“STG”) announced that a share buy-back programme of an aggregated price of up to DKK 600 million was launched with the purpose to adjust the Company’s capital structure and meet obligations relating to the Group’s share-based incentive programme. The buy-back programme is executed in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (the “Market Abuse Regulation”) and Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbour rules. The share buy-back programme will end no later than 28 February 2022. The following transactions have been executed from 19 July to 23 July 2021: Number of sharesAverage purchase price, DKKTransaction value, DKKAccumulated, last announcement1,781,412222,947,59319 July 202120,000125.242,504,78020 July 202115,510125.551,947,26

Saniona Receives U.S. FDA Orphan Drug Designation for Tesomet in Hypothalamic Obesity26.7.2021 08:00:00 CEST | Press release

PRESS RELEASE July 26, 2021 Tesomet is the first and only investigational treatment for hypothalamic obesity to receive orphan drug designation Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to Tesomet for the treatment of hypothalamic obesity (HO). Tesomet is the first and only investigational treatment for HO to receive orphan drug designation. Saniona is preparing to initiate two Phase 2b studiesof Tesomet in the second half of this year, one in HO and the other in Prader-Willi syndrome (PWS), for which Tesomet has already received orphan drug status. “There are currently no FDA-approved medicines for hypothalamic obesity. Despite the devastating weight gain and hunger this rare disease can cause, there has been relatively little drug development specifically for HO. Saniona is proud to be pioneering a regulatory path forward for people li

SERSTECH AB: Half-year report 1 January – 30 June 202126.7.2021 08:00:00 CEST | Press release

Serstech Group Second quarter 2021 Net sales: KSEK 2 765 (308)Profit for the period: KSEK -5 299 (-6 820)Earnings per share: SEK -0.06 (-0.10)Earnings per average number of shares: SEK -0.07 (-0.10) Serstech Group Period 1 January - 30 June 2021 Net sales: KSEK 14 224 (6 321)Profit for the period: KSEK -2 270 (-10 025)Earnings per share: SEK -0.03 (-0.14)Earnings per average number of shares: SEK-0.03 (-0.14) The second quarter brought a slight increase in orders received compared to the previous quarter, but we clearly see remaining effects of the pandemic in most parts of the world. We have not lost any tenders during the quarter, which is encouraging and again suggests that there is an unmet demand in the market. We do expect an increase in sales over the next six months, as the buyers become more active and the important demo sessions can be arranged safely again. Buyers in our industry will not buy an instrument they have not tested themselves and therefore they postpone procureme

Reminder of an Investor Conference Webinar26.7.2021 08:00:00 CEST | Press release

We would like to remind that KN invites shareholders, investors, analysts and other stakeholders to join its investor conference webinar scheduled on the July 29th of 2021 at 9.00 am (EET). The presentation will be held in English. The webinar will be hosted by KN Chief Executive Officer Darius Šilenskis and acting Chief Financial Officer Indrė Kisielienė who will introduce the performance and unaudited financial results of KN for the six months of 2021. How to join the webinar? To join the webinar, please register via following link: will be provided with the webinar link and instructions how to join successfully. When joining the webinar for the first time, you will be asked to download the plug-in which will take only few seconds. In case plug-in can't be downloaded, a web browser which enables attending the webinar, opens automatically. The webinar will be recorded and available online for everyone at the company’s we

Van Lanschot Kempen’s partnership with Mercier Vanderlinden finalised26.7.2021 08:00:00 CEST | Press release

’s-Hertogenbosch/Amsterdam, the Netherlands, 26July2021 Van Lanschot Kempen and Mercier Vanderlinden today announced that they have completed the transaction that sees Van Lanschot Kempen acquire a 70% stake in Mercier Vanderlinden. The regulators have issued declarations of no objection, and Van Lanschot Kempen and Mercier Vanderlinden have thus joined forces in the Belgian wealth management market. Van Lanschot Kempen will increase step-by-step its 70% stake in Mercier Vanderlinden to 100%. Mercier Vanderlinden and Van Lanschot Kempen in Belgium will continue to operate independently and collaborate in a number of areas. The partners are a good fit in terms of client portfolios and networks, product offering and geographical coverage. Between them, they had €9.3 billion in client assets at 30 June 2021. In the past few years, both Van Lanschot Kempen in Belgium and Mercier Vanderlinden have achieved robust client asset growth, and they will continue their role as market challengers o